Drug class
Cardiac Myosin Inhibitor
Mechanism of action
Cardiac Myosin Inhibitors [MoA]
General use cases
- Cardiomyopathy, Hypertrophic
- adults and pediatric patients weighing 30 kg or more with symptomatic obstructive hypertrophic cardiomyopathy (HCM) to improve functional capacity and symptoms
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
